FDA clears Abbott Libre Duo 10-day dual glucose/ketone monitor
The FDA clears Abbott’s Libre Duo 10-day dual glucose ketone monitor, described as the first in the US to track ketones continuously.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.